Basilea Awarded Additional Funding from U.S. Medical Countermeasure Program for Ceftobiprole Development Antimicrobial Resistance September 28, 2020 …
BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2 Biodetection April 17, 2020 …
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients Industry News April 14, 2020 …
BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19 Industry News April 14, 2020 …
BARDA and Genentech to Accelerate Phase 3 Clinical Trial of a Novel COVID-19 Therapeutic Treatment Industry News April 6, 2020 …
JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic Medical Countermeasures April 1, 2020 …
Cue Health Awarded Federal Contract for 25-Minute Nasal Swab COVID-19 Test Biodetection March 31, 2020 …
BARDA Collaborates with DiaSorin, Mesa Biotech to Develop COVID-19 Rapid Diagnostics Biodetection March 24, 2020 …
HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine Medical Countermeasures February 18, 2020 …
J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics Medical Countermeasures February 18, 2020 …
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development Antimicrobial Resistance February 7, 2020 …
HHS, Regeneron Collaborate to Develop COVID-19 Treatment Using VelociSuite Technology Medical Countermeasures February 4, 2020 …
Seqirus’ Pandemic Flu Vaccine Approved: Next Generation Technology Strengthens Preparedness Medical Countermeasures February 3, 2020 …
